Download PDF
Eur J Pediatr Surg 2015; 25(04): 336-344
DOI: 10.1055/s-0035-1559815
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Eosinophilic Esophagitis in Children with Esophageal Atresia

Usha Krishnan
1   Department of Pediatric Gastroenterology, Sydney Children's Hospital, Sydney, New South Wales, Australia
› Author Affiliations
Further Information

Publication History

22 June 2015

25 June 2015

Publication Date:
24 August 2015 (online)

    Permissions and Reprints

Abstract

Recent studies have reported a higher prevalence of eosinophilic esophagitis in children with esophageal atresia. Under recognition of eosinophilic esophagitis in these patients may lead to excessive use of antireflux therapy and an escalation of interventions, including fundoplication, as symptoms may be attributed to gastroesophageal reflux disease. In addition, long-term untreated eosinophilic esophagitis may lead to recurrent strictures due to transmural esophageal inflammation, necessitating repeated dilatations. Eosinophilic esophagitis should be considered when children with esophageal atresia show persistent symptoms on standard antireflux treatment, increasing dysphagia, and recurrent strictures. Treatment has been found to not only significantly reduce intraepithelial eosinophil count, but also to improve symptoms, and to lower the occurrence of strictures and the need for dilatations. Future prospective studies are warranted in this area.

Keywords

esophageal atresia - tracheoesophageal fistula - eosinophilic esophagitis - children
 

  • References

  • 1 Little DC, Rescorla FJ, Grosfeld JL, West KW, Scherer LR, Engum SA. Long-term analysis of children with esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 2003; 38 (6) 852-856
    CrossrefPubMedGoogle Scholar
  • 2 Liacouras CA, Furuta GT, Hirano I , et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128 (1) 3-20.e6 , quiz 21–22
    CrossrefPubMedGoogle Scholar
  • 3 Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology?. J Allergy Clin Immunol 2005; 115 (2) 418-419
    CrossrefPubMedGoogle Scholar
  • 4 Dhaliwal J, Tobias V, Sugo E , et al. Eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus 2014; 27 (4) 340-347
    CrossrefPubMedGoogle Scholar
  • 5 Gorter RR, Heij HA, van der Voorn JP, Kneepkens CM. Eosinophilic esophagitis after esophageal atresia: is there an association? Case presentation and literature review. J Pediatr Surg 2012; 47 (6) e9-e13
    PubMedGoogle Scholar
  • 6 Pedersen RN, Markøw S, Kruse-Andersen S , et al. Esophageal atresia: gastroesophageal functional follow-up in 5-15 year old children. J Pediatr Surg 2013; 48 (12) 2487-2495
    CrossrefPubMedGoogle Scholar
  • 7 Batres LA, Liacouras C, Schnaufer L, Mascarenhas MR. Eosinophilic esophagitis associated with anastomotic strictures after esophageal atresia repair. J Pediatr Gastroenterol Nutr 2002; 35 (2) 224-226
    CrossrefPubMedGoogle Scholar
  • 8 Oliveira C, Zamakhshary M, Marcon P, Kim PC. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair: a case series. J Pediatr Surg 2008; 43 (5) 810-814
    CrossrefPubMedGoogle Scholar
  • 9 Yamada Y, Nishi A, Kato M , et al. Esophagitis with eosinophil infiltration associated with congenital esophageal atresia and stenosis. Int Arch Allergy Immunol 2013; 161 (Suppl. 02) 159-163
    CrossrefPubMedGoogle Scholar
  • 10 Kassabian S, Baez-Socorro V, Sferra T, Garcia R. Eosinophilic esophagitis in patients with esophageal atresia and chronic dysphagia. World J Gastroenterol 2014; 20 (47) 18038-18043
    CrossrefPubMedGoogle Scholar
  • 11 Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am 2003; 32 (3) 949-966
    CrossrefPubMedGoogle Scholar
  • 12 Pinheiro PF, Simões e Silva AC, Pereira RM. Current knowledge on esophageal atresia. World J Gastroenterol 2012; 18 (28) 3662-3672
    CrossrefPubMedGoogle Scholar
  • 13 Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108 (6) 954-961
    CrossrefPubMedGoogle Scholar
  • 14 Bullock JZ, Villanueva JM, Blanchard C , et al. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45 (1) 22-31
    CrossrefPubMedGoogle Scholar
  • 15 Blanchard C, Mingler MK, Vicario M , et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120 (6) 1292-1300
    CrossrefPubMedGoogle Scholar
  • 16 Bhattacharya B, Carlsten J, Sabo E , et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38 (12) 1744-1753
    CrossrefPubMedGoogle Scholar
  • 17 Stankiewicz P, Sen P, Bhatt SS , et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009; 84 (6) 780-791
    CrossrefPubMedGoogle Scholar
  • 18 Shaw-Smith C. Genetic factors in esophageal atresia, tracheo-esophageal fistula and the VACTERL association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature. Eur J Med Genet 2010; 53 (1) 6-13
    CrossrefPubMedGoogle Scholar
  • 19 Lou Y, Lu X, Dang X. FOXO1 up-regulates human l-selectin expression through binding to a consensus FOXO1 motif. Gene Regul Syst Bio 2012; 6: 139-149
    PubMedGoogle Scholar
  • 20 Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol 2011; 128 (1) 23-32 , quiz 33–34
    CrossrefPubMedGoogle Scholar
  • 21 Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux—damaged human esophageal epithelium. Gastroenterology 1996; 111 (5) 1200-1205
    CrossrefPubMedGoogle Scholar
  • 22 Allen KJ, Heine RG. Eosinophilic esophagitis: trials and tribulations. J Clin Gastroenterol 2011; 45 (7) 574-582
    CrossrefPubMedGoogle Scholar
  • 23 Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol 2008; 121 (6) 1301-1308 , quiz 1309–1310
    CrossrefPubMedGoogle Scholar
  • 24 Diesner SC, Knittelfelder R, Krishnamurthy D , et al. Dose-dependent food allergy induction against ovalbumin under acid-suppression: a murine food allergy model. Immunol Lett 2008; 121 (1) 45-51
    CrossrefPubMedGoogle Scholar
  • 25 Untersmayr E, Schöll I, Swoboda I , et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003; 112 (3) 616-623
    CrossrefPubMedGoogle Scholar
  • 26 McKinnon LJ, Kosloske AM. Prediction and prevention of anastomotic complications of esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 1990; 25 (7) 778-781
    CrossrefPubMedGoogle Scholar
  • 27 Yanchar NL, Gordon R, Cooper M, Dunlap H, Soucy P. Significance of the clinical course and early upper gastrointestinal studies in predicting complications associated with repair of esophageal atresia. J Pediatr Surg 2001; 36 (5) 815-822
    CrossrefPubMedGoogle Scholar
  • 28 Liacouras CA, Ruchelli E. Eosinophilic esophagitis. Curr Opin Pediatr 2004; 16 (5) 560-566
    CrossrefPubMedGoogle Scholar
  • 29 Aceves SS, Newbury RO, Chen D , et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65 (1) 109-116
    CrossrefPubMedGoogle Scholar
  • 30 Chan LJ, Tan L, Dhaliwal J, Briglia F, Clarkson C, Krishnan U. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus 2015; (e-pub ahead of print). doi: 10.1111/dote.12368
    PubMedGoogle Scholar
  • 31 Spergel JM, Brown-Whitehorn TF, Cianferoni A , et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012; 130 (2) 461-7.e5
    CrossrefPubMedGoogle Scholar
  • 32 McLennan L, Clarkson C, Hughes J , et al. Quality of life in children with eosinophilic esophagitis associated with esophageal atresia and tracheoesophageal fistula [Posters Exhibition]. The 3rd International Conference on Esophageal Atresia. October 2–3, 2014; Rotterdam, NL
    PubMedGoogle Scholar
  • 33 Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol 2006; 118 (5) 1054-1059
    CrossrefPubMedGoogle Scholar
  • 34 Furuta GT, Liacouras CA, Collins MH , et al; First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133 (4) 1342-1363
    CrossrefPubMedGoogle Scholar
  • 35 Sayej WN, Patel R, Baker RD, Tron E, Baker SS. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 49 (4) 393-399
    CrossrefPubMedGoogle Scholar
  • 36 Pentiuk SP, Miller CK, Kaul A. Eosinophilic esophagitis in infants and toddlers. Dysphagia 2007; 22 (1) 44-48
    CrossrefPubMedGoogle Scholar
  • 37 Kakakios A, Heine RG. Eosinophilic oesophagitis. Med J Aust 2006; 185 (7) 401
    PubMedGoogle Scholar
  • 38 Zhang X, Cheng E, Huo X , et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE 2012; 7 (11) e50037
    CrossrefPubMedGoogle Scholar
  • 39 Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009; 54 (11) 2312-2317
    CrossrefPubMedGoogle Scholar
  • 40 Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 2003; 278 (13) 10993-11001
    CrossrefPubMedGoogle Scholar
  • 41 Cheng E, Zhang X, Huo X , et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013; 62 (6) 824-832
    CrossrefPubMedGoogle Scholar
  • 42 Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 2012; 57 (5) 1413-1419
    CrossrefPubMedGoogle Scholar
  • 43 Ferguson DD, Foxx-Orenstein AE. Eosinophilic esophagitis: an update. Dis Esophagus 2007; 20 (1) 2-8
    CrossrefPubMedGoogle Scholar
  • 44 Konikoff MR, Noel RJ, Blanchard C , et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131 (5) 1381-1391
    CrossrefPubMedGoogle Scholar